Cas:4378-55-6 5-(3,4-dimethoxyphenyl)-5-oxopentanoic acid manufacturer & supplier

Chemical Name:5-(3,4-dimethoxyphenyl)-5-oxopentanoic acid

CAS.NO:4378-55-6

Synonyms:5-(3,4-dimethoxyphenyl)-5-oxopentanoic acid

Molecular Formula:C₁₃H₁₆O₅

Molecular Weight:252.26300

HS Code:2918990090

Physical and Chemical Properties:

Melting point:145-146ºC

Boiling point:451.8ºC at 760 mmHg

Density:1.183g/cm3

Index of Refraction:1.522

PSA:72.83000

Exact Mass:252.10000

LogP:2.14140

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 5-(3,4-dimethoxyphenyl)-5-oxopentanoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-(3,4-dimethoxyphenyl)-5-oxopentanoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-(3,4-dimethoxyphenyl)-5-oxopentanoic acid Use and application,5-(3,4-dimethoxyphenyl)-5-oxopentanoic acid technical grade,usp/ep/jp grade.

Related News: Our COVID-19 vaccine, Vaxzevria, undergoes extremely robust safety and quality testing prior to becoming available for patients. 7-chloro-2-methyl-3-(3-methyl-pyridin-2-yl)-4-oxo-1,2,3,4-tetrahydro-quinazoline-6-sulfonic acid amide manufacturers In response, the strategy sets out how government will work with institutions, businesses, funders and charities to drive change in the sector, with new initiatives to encourage more young people into research, broaden career pathways in the sector and look further into the impacts of bureaucracy on researchers. 1,2,4-Triazine,3-(2-chloro-4-fluorophenyl)-2-(2-ethyl-1-oxohexyl)-6-(4′-fluoro[1,1′-biphenyl]-4-yl)-2,5-dihydro-5-methyl- suppliers An inherent advantage of using enzymes for synthetic chemistry is that they increase regio-, enantio-, and stereoselectivity for more efficient conversion of substrate to product. 1-((2,2-bis(hydroxymethyl)cyclopropyl)methyl)-6-(3,5-dimethylphenoxy)-5-ethylpyrimidine-2,4(1H,3H)-dione vendor & factory The use of the Spikevax vaccine in children from 12 to 17 years of age will be the same as in people aged 18 and above, EMA said.,Our COVID-19 vaccine, Vaxzevria, undergoes extremely robust safety and quality testing prior to becoming available for patients.